| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 10,280,620 | 99,722,000 | 7.46% | ||
| 2 | MEDIVATION INC | 1,599,393 | 77,315,000 | 5.79% | ||
| 3 | PENUMBRA INC COM | 1,537,570 | 76,213,000 | 5.70% | ||
| 4 | ARRAY BIOPHARMA INC COM | 17,850,650 | 75,330,000 | 5.64% | ||
| 5 | INTRA CELLULAR THERAPIES INC COM | 1,223,717 | 65,824,000 | 4.93% | ||
| 6 | CLOVIS ONCOLOGY INC | 1,795,936 | 62,858,000 | 4.70% | ||
| 7 | SEATTLE GENETICS INC | 1,372,492 | 61,597,000 | 4.61% | ||
| 8 | TEVA PHARMACEUTICAL INDS LTD | 938,139 | 61,579,000 | 4.61% | ||
| 9 | SAGE THERAPEUTICS | 958,374 | 55,873,000 | 4.18% | ||
| 10 | PORTOLA PHARMACEUTICALS INC | 958,155 | 49,297,000 | 3.69% | ||
| 11 | WELLCARE HEALTH PLANS INC COM | 562,873 | 44,022,000 | 3.29% | ||
| 12 | IRONWOOD PHARMACEUTICALS INC COM CL A | 3,671,344 | 42,551,000 | 3.18% | ||
| 13 | BOSTON SCIENTIFIC CORP | 2,251,020 | 41,509,000 | 3.11% | ||
| 14 | PFIZER INC | 1,260,400 | 40,686,000 | 3.04% | Call | |
| 15 | Atara Biotherapeutics Inc | 1,534,962 | 40,538,000 | 3.03% | ||
| 16 | INCYTE | 357,912 | 38,816,000 | 2.90% | ||
| 17 | Diplomat Pharmacy Inc | 1,115,902 | 38,186,000 | 2.86% | ||
| 18 | NEVRO CORP | 415,198 | 28,030,000 | 2.10% | ||
| 19 | NEURODERM LTD | 1,589,261 | 27,097,000 | 2.03% | ||
| 20 | CENTENE CORP DEL | 408,000 | 26,850,000 | 2.01% | ||
| 21 | INSMED INC COM PAR .01 | 1,391,813 | 25,261,000 | 1.89% | ||
| 22 | UNITEDHEALTH GROUP INC | 187,034 | 22,003,000 | 1.65% | ||
| 23 | ALLERGAN PLC | 68,758 | 21,487,000 | 1.61% | ||
| 24 | Model N Inc | 1,868,159 | 20,849,000 | 1.56% | ||
| 25 | ZELTIQ AESTHETICS INCORPORATED | 709,426 | 20,240,000 | 1.51% | ||
| 26 | NANOSTRING TECHNOLOGIES INC | 1,357,692 | 19,972,000 | 1.49% | ||
| 27 | WAVE LIFE SCIENCES LTD | 1,213,627 | 18,326,000 | 1.37% | ||
| 28 | CYTOMX THERAPEUTICS INC COM | 738,356 | 14,405,000 | 1.08% | ||
| 29 | HEALTH NET INC | 181,029 | 12,393,000 | 0.93% | ||
| 30 | ENDOLOGIX INC | 1,007,177 | 9,971,000 | 0.75% | ||
| 31 | Oxford Immunotec Global PLC | 860,288 | 9,893,000 | 0.74% | ||
| 32 | CHARLES RIV LABS INTL INC | 122,400 | 9,840,000 | 0.74% | ||
| 33 | TRIVASCULAR TECHNOLOGIES INC | 1,462,762 | 9,727,000 | 0.73% | ||
| 34 | FATE THERAPEUTICS INC COM | 2,371,001 | 7,990,000 | 0.60% | ||
| 35 | PRESS GANEY HLDGS INC | 239,616 | 7,560,000 | 0.57% | ||
| 36 | BLUEPRINT MEDICINES CORP COM | 276,687 | 7,288,000 | 0.55% | ||
| 37 | GLOBAL BLOOD THERAPEUTICS IN COM | 218,718 | 7,071,000 | 0.53% | ||
| 38 | DURECT CORP | 2,628,416 | 5,809,000 | 0.43% | ||
| 39 | INVITAE CORP | 660,129 | 5,420,000 | 0.41% | ||
| 40 | ONCOTHYREON INC COM N/C EFF 6/ | 2,331,300 | 5,175,000 | 0.39% | ||
| 41 | ProQR Therapeutics NV | 557,193 | 4,836,000 | 0.36% | ||
| 42 | PFIZER INC | 123,800 | 3,996,000 | 0.30% | ||
| 43 | ARRAY BIOPHARMA INC 3 06/01/2020 | 4,000,000 | 3,702,000 | 0.28% | PRN | |
| 44 | ELEVEN BIOTHERAPEUTICS INC | 875,857 | 2,636,000 | 0.20% | ||
| 45 | CONFORMIS INC | 125,709 | 2,174,000 | 0.16% | ||
| 46 | CELGENE CORP | 10,055 | 1,204,000 | 0.09% | ||
| 47 | ISHARES TRUST US HLTHCR PR ETF | 4,520 | 562,000 | 0.04% | ||
| 48 | CHEMOCENTRYX INC | 63,189 | 512,000 | 0.04% | ||
| 49 | ProNAi Therapeutics, Inc. | 24,787 | 373,000 | 0.03% | ||
| 50 | FLUIDIGM CORP DEL COM | 32,561 | 352,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001425738-16-000035, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
